IIMPACT Health 2021 organized by TiE Mumbai & IIMA Healthcare ASIG

IIMPACT Health 2021

IIMPACT Health 2021: TiE Mumbai, in partnership with IIM Ahmedabad’s Alumni led Healthcare interest Group, is organizing a two-day conclave, IIMPACT HEALTH 2021- Global shifts, disruptions and therefore the age of UNICORNS scaling Healthcare Innovation in India on September 16-17, 2021.

This marquee HealthTech conclave, IIMPACT Health 2021 will compile thought leaders, VCs, successful Indian and global healthcare & healthtech entrepreneurs, to decode what it takes to create an outsized , successful, healthcare company in India.

Key speakers at this event are Kiran Mazumdar Shaw, executive chairperson, Biocon Biologics who are going to be engaging during a Fireside chat and Axel Baur, senior partner & pharma and healthcare practice leader, Asia, Mckinsey & Company who are going to be delivering the opening keynote. Other marquee speakers at the event are Umang Vohra- MD & global CEO, Cipla, Sridhar S – MD, Pfizer Ltd, Shravan Subramanyam – president & CEO, GE & MD Wipro GE Healthcare, Pallavi Jain- MD, Krsnaa Diagnostics, Dr. Dhaval Shah- co-founder, PharmEasy, RizwanKoita- CEO, CitiusTech and KanavHasija- co-founder, chief customer officer, InnovAccer among others.

“Globally, healthcare and HealthTech are amongst the highest 5 sectors to scale successfully to unicorn status. Lately many healthcare unicorns are born out of India, which is extremely encouraging for the Startup sector. This conclave are going to be both interesting and educative with regards to how the Healthcare Industry can catapult forward.” said Amit Mookim, president, TiE Mumbai.

“India’s healthcare sector is poised for accelerated growth. to know the opportunities in healthcare, IMPACT 2021 is getting the simplest of the minds together on one platform making it an occasion you can’t miss,” said Sudarshan Jain, Secretary General , Indian Pharmaceutical Alliance and anchor IIMA Healthcare ASIG.

Healthcare companies globally have cumulatively raised over US$ 10 billion over the last decade. They represent a huge sort of companies – from regenerative medicine, drug development, online physician service, appointment booking, insurance , wellness apps, amongst others. Healthcare superstars have emerged from just about across the world like the US, China, UK, Germany, Israel, France and South Korea .

Simultaneously, the start-up landscape in India has matured significantly also . Several Indian start-ups across sectors have managed to scale successfully, with 11 start-ups joining the vaulted Unicorn club in 2020 alone. Indian healthcare start-ups have began to see success. 2021 has been an excellent year for Indian Healthtech, with Pharmeasy -becoming India’s first Healthtech unicorn, and Krsnaa Diagnostics – a teleradiology player, getting a successful IPO.

IIMPACT Health 2021 takes a holistic 360 degree view of the healthcare sector and therefore the start-up ecosystem in India.

Be the first to comment on "IIMPACT Health 2021 organized by TiE Mumbai & IIMA Healthcare ASIG"

Leave a comment

Your email address will not be published.


*